Kyoko Miyamoto, Robert M. Miller, Christine Voors‐Pette, Jart A. F. Oosterhaven, Marieke van denDobbelsteen, Katsuhiro Mihara, . . . Akinori Arimura. (2024). Safety, pharmacokinetics, and pharmacodynamics of sofnobrutinib, a novel non‐covalent BTK inhibitor, in healthy subjects: First‐in‐human phase I study. Wiley.
Chicago Style (17th ed.) CitationKyoko Miyamoto, et al. Safety, Pharmacokinetics, and Pharmacodynamics of Sofnobrutinib, a Novel Non‐covalent BTK Inhibitor, in Healthy Subjects: First‐in‐human Phase I Study. Wiley, 2024.
MLA (9th ed.) CitationKyoko Miyamoto, et al. Safety, Pharmacokinetics, and Pharmacodynamics of Sofnobrutinib, a Novel Non‐covalent BTK Inhibitor, in Healthy Subjects: First‐in‐human Phase I Study. Wiley, 2024.
Warning: These citations may not always be 100% accurate.